Efficacy and Cardiovascular Safety of LAMA in Patients with COPD: A Systematic Review and Meta-Analysis - Chuchu Zhang, Meng Zhang, Yalei Wang, Huaiyu Xiong, Qiangru Huang, Tiankui Shuai, Jian Liu, 2021
Emerging role of long acting muscarinic antagonists for asthma - Lipworth - 2014 - British Journal of Clinical Pharmacology - Wiley Online Library
Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/4-Table1-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
An additional effect of short-acting muscarinic antagonists plus... | Download Scientific Diagram
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Natalies Casebook | Tag
Bronchodilators: Beta 2-agonists and muscarinic antagonists | Osmosis
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
Understanding the role of long-acting muscarinic antagonists in asthma treatment - Annals of Allergy, Asthma & Immunology
Muscarinic antagonist - Wikipedia
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Practical considerations when prescribing a long-acting muscarinic ant | COPD
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial - The Lancet
Full article: Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society
New developments in inhaled therapy | Practice Nursing
Muscarinic antagonists: Video, Anatomy & Definition | Osmosis
Long-acting muscarinic antagonists for the treatment of asthma in children—a new kid in town | Allergo Journal International
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table2-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Pharmacological management of COPD .SABA = short-acting beta 2... | Download Scientific Diagram
Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain | npj Primary Care Respiratory Medicine
